{"id":"W4310753261","doi":"10.1016/j.annonc.2022.10.324","title":"296P Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada); Princess Margaret Cancer Centre; University Health Network","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; T790M; Adjuvant; Internal medicine; Lung cancer; Oncology; non-small cell lung cancer (NSCLC); Chemotherapy; Stage (stratigraphy); Cancer; Epidermal growth factor receptor; Erlotinib; Gefitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001703513,0.0006130117,0.001966561,0.0009329684,0.0001429631,0.001251144,0.0007038997,0.0005852646,0.001364556],"category_scores_gemma":[0.002431137,0.0002660093,0.002320631,0.001951198,0.0002105116,0.0007095646,0.0003646866,0.001035595,0.0003387564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001172572,"about_ca_system_score_gemma":0.0013091,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006474403,"about_ca_topic_score_gemma":0.02395521,"domain_scores_codex":[0.9993683,0.0001680638,0.0001001786,0.00009060176,0.0002064852,0.0000664946],"domain_scores_gemma":[0.9985319,0.000480202,0.0005798494,0.00005612784,0.0002485704,0.0001033273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.06585871,0.0007398076,0.109808,0.01252829,0.01541688,0.0004798881,0.0002354368,0.002367765,0.004823519,0.0004108314,0.03914017,0.7481908],"study_design_scores_gemma":[0.03539877,0.0125267,0.7234645,0.005250096,0.06640092,0.001942373,0.0003752566,0.001634991,0.003421167,0.0007779697,0.1485815,0.0002257518],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.4036344,0.5345189,0.001037442,0.004799685,0.00178753,0.0006067856,0.03451533,0.0001786904,0.01892127],"genre_scores_gemma":[0.7106004,0.2373858,0.0038401,0.006660251,0.001828247,0.0006156719,0.03367411,0.00009881423,0.005296691],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.006474403,"threshold_uncertainty_score":0.01287341,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0326366005939003,"score_gpt":0.3717841875002906,"score_spread":0.3391475869063904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}